background ebola virus response number outbreak since recent outbreak take place caps intern public health emerge disease end high mortal rate approve target treatment exist date number establish drug consider potent therapeutic agent object aim identify drug deposit candid ass scientific revid avail efficacy method conduct system literature search merlin embassy elev trial registry platform studi publish january include screen prelim clinic repurposed risk bia anim nonrandom ass quality report case semi report value final select regulatory author post vitro studi outcome least one admit result identify public fulfil include criterion highly heterogen term type methodology intervene antievd effect summary concur sever may quantity current lack review highlight need welldesign research establish 